Sharewise Webinar with Race Oncology CEO Daniel Tillett

Watch our webinar with Sharewise, featuring CEO Daniel Tillett.
The webinar features a presentation, followed by a live Q&A.
Key topics:
- Background to Race Oncology and their developments
- What bisantrene could mean for cancer patients around the world
- Why cardioprotection is so important in regards to cancer treatment
- What stage they are at with the clinical development process
- The company's upcoming milestones
- Why investors should be interested in Race Oncology